ResearchMoz

Radiculopathy Global Clinical Trials Review, Q1, 2011

Publisher Name » GlobalData
Published Date » 2011-03-15
No. Of Pages » 35

GlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, Q1, 2011 provides data on the Radiculopathy clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Radiculopathy . It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Radiculopathy . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Radiculopathy 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by Phase 12
In Progress Trials by Phase 13
Clinical Trials by Trial Status 14
Subjects Recruited Over a Period of Time 15
Prominent Sponsors 16
Top Companies Participating in Radiculopathy Therapeutics Clinical Trials 18
Prominent Drug Comparison 19
Clinical Trial Profiles 20
Clinical Trial Overview of Top Companies 20
Legend Healthcare 20
Clinical Trial Overview of Legend Healthcare 20
Celgene Corporation 21
Clinical Trial Overview of Celgene Corporation 21
GlaxoSmithKline plc 22
Clinical Trial Overview of GlaxoSmithKline plc 22
Clinical Trial Overview of Top Universities / Institutes / Hospitals 23
Medical Center Haaglanden 23
Clinical Trial Overview of Medical Center Haaglanden 23
University of Utah Health Care 24
Clinical Trial Overview of University of Utah Health Care 24
Saint John Regional Hospital 25
Clinical Trial Overview of Saint John Regional Hospital 25
Singapore General Hospital 26
Clinical Trial Overview of Singapore General Hospital 26
Ruhr University Bochum 27
Clinical Trial Overview of Ruhr University Bochum 27
Norwegian University of Science and Technology 28
Clinical Trial Overview of Norwegian University of Science and Technology 28
Johns Hopkins University 29
Clinical Trial Overview of Johns Hopkins University 29
National Institute of Dental and Craniofacial Research 30
Clinical Trial Overview of National Institute of Dental and Craniofacial Research 30
LifeNet Health Inc. 31
Clinical Trial Overview of LifeNet Health Inc. 31

Appendix 32
Abbreviations 32
Definitions 32
Research Methodology 33
Secondary Research 33
About GlobalData 34
Contact Us 34
Disclaimer 35
Source 35

List of Tables


Radiculopathy Therapeutics Market, Global, Clinical Trials by Zone, 2011* 6
Radiculopathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 7
Radiculopathy Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 8
Radiculopathy Therapeutics Clinical Trials, Asia-Pacific ,Top Countries, 2011* 9
Radiculopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 10
Radiculopathy Therapeutics Clinical Trials, North America, Top Countries, 2011* 11
Radiculopathy Therapeutics Market, Global, Clinical Trials by Phase, 2011* 12
Radiculopathy Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011* 13
Radiculopathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 14
Radiculopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 15
Radiculopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 17
Radiculopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 18
Radiculopathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 19
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Legend Healthcare, 2011* 20
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2011* 21
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 22
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Center Haaglanden, 2011* 23
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Utah Health Care, 2011* 24
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Saint John Regional Hospital, 2011* 25
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Singapore General Hospital, 2011* 26
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ruhr University Bochum, 2011* 27
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2011* 28
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2011* 29
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Dental and Craniofacial Research, 2011* 30
Radiculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by LifeNet Health Inc., 2011* 31

List of Figures


Radiculopathy Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 6
Radiculopathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 7
Radiculopathy Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 8
Radiculopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 10
Radiculopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 11
Radiculopathy Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 12
Radiculopathy Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011* 13
Radiculopathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 14
Radiculopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 15
Radiculopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 16
Radiculopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 18
Radiculopathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 19
GlobalData Methodology 33

Upcoming Reports:

Marine-Derived Pharmaceuticals Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast, 2012 - 2018
By - Transparency Market Research
Description Marine derived pharmaceuticals are the drugs and other pharmacological substances which are made from extracting elements present in marine life. Although the concept of marine ethnomedicine dates back to the 18th and 19th century, actual exploratory work on marine pharmacology began in the mid and late 1960s when groups of chemists in the United States, Japan, and Europe began to explore sponges, marine algae, and other forms of marine life for their medicinal properties.  At present there are several marine-derived pharmaceuticals available in the...
Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
By - Transparency Market Research
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, immature blood cells are present in the bone marrow. Symptoms found in patients due to the disease are flu, loss of weight, body ache and pain and spots on skin.  The Acute Myeloid Leukemia (AML) therapeutics market was USD 239.3 million in 2011 and this market is forecasted to...
Unconventional Natural Gas Extraction Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Natural gas obtained from coal, gas shale, and gas hydrates are generally referred to as unconventional natural gases. There has been a rapid growth in the exploration and production of unconventional natural gas due to the need for power generation. Technological improvements in the extraction methods like drilling and hydraulic fracturing and benefits of natural gas over other fuels for power generation are some important reasons driving this market.  Widespread availability of unconventional natural gas resources is also adding to their increasing use in the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...